Russell Frank Company’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Russell Frank Company’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-4,700	Closed	-$37K	–	3061
2015 Q4	$37K	Sell	4,700 -214,281	-98%	-$1.84M	﹤0.01%	2913
2015 Q3	$1.85M	Sell	218,981 -50,900	-19%	-$470K	﹤0.01%	1893
2015 Q2	$2.96M	Buy	269,881 +86,647	+47%	+$1.11M	﹤0.01%	1753
2015 Q1	$2.56M	Buy	183,234 +66,052	+56%	+$1.01M	﹤0.01%	1641
2014 Q4	$1.98M	Buy	117,182 +51,570	+79%	+$751K	﹤0.01%	1805
2014 Q3	$881K	Buy	+65,612	New	+$781K	﹤0.01%	2115
2013 Q4	–	Sell	-7,230	Closed	-$126K	–	3124
2013 Q3	$126K	Buy	7,230 +105	+1%	+$2.01K	﹤0.01%	2906
2013 Q2	$116K	Buy	+7,125	New	+$220K	﹤0.01%	2707

Other funds holding INFI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

Russell Frank Company's INFI Position: Q1 2016 in Review

Russell Frank Company sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q1 2016, closing a stake of 4,700 shares — an estimated $37K sold.

Russell Frank Company first reported a position in INFI in Q2 2013 and held it in 8 quarters. The position peaked at $2.96M in Q2 2015. 117 funds tracked by Wall St. Rank hold INFI as of Q1 2016.

Russell Frank Company reported no remaining Infinity Pharmaceuticals, Inc. position as of Q1 2016 after selling out during the quarter.
Russell Frank Company sold 4,700 Infinity Pharmaceuticals, Inc. shares in Q1 2016, an estimated $37K.
Russell Frank Company first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 8 quarters.
Russell Frank Company's Infinity Pharmaceuticals, Inc. position peaked at $2.96M in Q2 2015.
117 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.